 | Up a level |
Ferreri, Andres J. M., Cwynarski, Kate, Pulczynski, Elisa, Fox, Christopher P., Schorb, Elisabeth, Celico, Claudia, Falautano, Monica, Nonis, Alessandro, La Rosee, Paul 
ORCID: 0000-0002-6758-7809, Binder, Mascia, Fabbri, Alberto, Ilariucci, Fiorella, Krampera, Mauro, Roth, Alexander, Hemmaway, Claire, Johnson, Peter W., Linton, Kim M., Pukrop, Tobias, Gorlov, Jettes Sonderskov, Balzarotti, Monica, Hess, Georg, Keller, Ulrich, Stilgenbauer, Stephan, Panse, Jense, Tucci, Alessandra, Orsucci, Lorella, Pisani, Francesco, Zanni, Manuela, Krause, Stefan W., Schmoll, Hans J., Hertenstein, Bernd, Rummel, Mathias, Smith, Jeffery, Thurner, Lorenz, Cabras, Giuseppina, Pennese, Elsa, Ponzoni, Maurilio, Deckert, Martina, Politi, Letterio S., Finke, Jurgen, Ferranti, Antonella, Cozens, Kelly, Burger, Elvira, Ielmini, Nicoletta, Cavalli, Franco, Zucca, Emanuele and Illerhaus, Gerald
(2022).
Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial.
Leukemia, 36 (7).
S. 1870 - 1879.
LONDON:
SPRINGERNATURE.
ISSN 1476-5551
Koehler, Philipp ORCID: 0000-0002-7386-7495, Hamprecht, Axel ORCID: 0000-0003-1449-5780, Bader, Oliver ORCID: 0000-0002-1534-440X, Bekeredjian-Ding, Isabelle ORCID: 0000-0001-6646-5888, Buchheidt, Dieter ORCID: 0000-0002-4425-6134, Doelken, Gottfried, Elias, Johannes ORCID: 0000-0002-5878-7040, Haase, Gerhard ORCID: 0000-0001-7771-3189, Hahn-Ast, Corinna, Karthaus, Meinolf, Kekule, Alexander, Keller, Peter, Kiehl, Michael, Krause, StefanW., Karmer, Carolin, Neumann, Silke, Rohde, Holger, La Rosee, Paul ORCID: 0000-0002-6758-7809, Ruhnke, Markus, Schafhausen, Philippe, Schalk, Enrico ORCID: 0000-0003-1892-5098, Schulz, Katrin, Schwartz, Stefan ORCID: 0000-0001-8833-5793, Silling, Gerda, Staib, Peter, Ullmann, Andrew, Vergoulidou, Maria, Weber, Thomas, Cornely, Oliver A. and Vehreschild, Maria J. G. T.
(2017).
Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study.
Int. J. Antimicrob. Agents, 49 (2).
S. 218 - 224.
AMSTERDAM:
ELSEVIER.
ISSN 1872-7913
Ferreri, Andres J. M., Cwynarski, Kate, Pulczynski, Elko, Ponzoni, Mourilio, Deckert, Martina, Politi, Letterio S., Torri, Valter ORCID: 0000-0001-9541-9354, Fox, Christopher P., La Rosee, Paul ORCID: 0000-0002-6758-7809, Schorb, Elisabeth, Ambrosetti, Achille, Roth, Alexander, Hemmoway, Claire, Ferrari, Angela ORCID: 0000-0002-9984-1146, Linton, Kim M., Ruda, Roberta, Binder, Mascha ORCID: 0000-0003-0663-3004, Pukrop, Tobias, Balzarotti, Monica, Fabbri, Alberto, Johnson, Peter, Gorlov, Jette Sonderskov, Hess, Georg, Panse, Jens, Pisani, Francesco, Tucci, Alessandra ORCID: 0000-0003-3052-7463, Stilgenbauer, Stephan, Hertenstein, Bernd, Keller, Ulrich, Krause, Stefan W., Levis, Alessandro, Schmoll, Hans J., Covalli, Franco, Finke, Jurgen, Reni, Michele ORCID: 0000-0002-6463-0293, Zucca, Emanuele ORCID: 0000-0002-5522-6109 and Illerhaus, Gerald
(2016).
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.
Lancet Haematol., 3 (5).
S. E217 - 11.
OXFORD:
ELSEVIER SCI LTD.
ISSN 2352-3026